KR890700352A - 히드라진 설페이트를 사용하여 암환자의 생존을 연장시키는 방법 - Google Patents

히드라진 설페이트를 사용하여 암환자의 생존을 연장시키는 방법

Info

Publication number
KR890700352A
KR890700352A KR1019880701513A KR880701513A KR890700352A KR 890700352 A KR890700352 A KR 890700352A KR 1019880701513 A KR1019880701513 A KR 1019880701513A KR 880701513 A KR880701513 A KR 880701513A KR 890700352 A KR890700352 A KR 890700352A
Authority
KR
South Korea
Prior art keywords
survival
extend
hydrazine sulfate
cancer patients
hydrazine
Prior art date
Application number
KR1019880701513A
Other languages
English (en)
Other versions
KR970005183B1 (ko
Inventor
죠셉골드
Original Assignee
죠셉골드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 죠셉골드 filed Critical 죠셉골드
Publication of KR890700352A publication Critical patent/KR890700352A/ko
Application granted granted Critical
Publication of KR970005183B1 publication Critical patent/KR970005183B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/02—Ammonia; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1019880701513A 1987-03-27 1988-03-16 히드라진 설페이트를 함유하는 약제 KR970005183B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3205187A 1987-03-27 1987-03-27
US032,051 1987-03-27
PCT/US1988/000950 WO1988007372A1 (en) 1987-03-27 1988-03-16 Method of prolonging cancerous patient survival in humans with hydrazine sulfate

Publications (2)

Publication Number Publication Date
KR890700352A true KR890700352A (ko) 1989-04-24
KR970005183B1 KR970005183B1 (ko) 1997-04-14

Family

ID=21862837

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019880701513A KR970005183B1 (ko) 1987-03-27 1988-03-16 히드라진 설페이트를 함유하는 약제

Country Status (7)

Country Link
EP (1) EP0354917B1 (ko)
JP (1) JP2718733B2 (ko)
KR (1) KR970005183B1 (ko)
AT (1) ATE106246T1 (ko)
AU (1) AU613031B2 (ko)
DE (1) DE3889912T2 (ko)
WO (1) WO1988007372A1 (ko)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4110437A (en) * 1975-03-14 1978-08-29 Joseph Gold Method of treating cancerous cachexia in humans with hydrazine sulfate

Also Published As

Publication number Publication date
EP0354917B1 (en) 1994-06-01
JPH02503197A (ja) 1990-10-04
EP0354917A4 (en) 1990-12-05
WO1988007372A1 (en) 1988-10-06
ATE106246T1 (de) 1994-06-15
DE3889912T2 (de) 1994-12-01
EP0354917A1 (en) 1990-02-21
JP2718733B2 (ja) 1998-02-25
DE3889912D1 (de) 1994-07-07
KR970005183B1 (ko) 1997-04-14
AU613031B2 (en) 1991-07-25
AU1598388A (en) 1988-11-02

Similar Documents

Publication Publication Date Title
ES2071484T3 (es) Derivados de 2,4-diaminoquinazolinas para aumentar la actividad antitumoral.
MY103388A (en) Azithromycin and derivatives as antiprotozoal agents
OA08724A (fr) Treatment of human viral infections by dsRNA combined with viral inhibitors.
DK554084A (da) 26,26,26,27,27,27-hexafluor-1alfa,25-dihydroxycholesterol
DE3774918D1 (de) Cancerostatisches mittel.
ES512897A0 (es) Procedimiento de obtencion de composiciones para el tratamiento de enfermedades intestinales en mamiferos.
IT8248666A0 (it) Procedimento per produrre i glicosa minoglicani dermatansolfato ed eparan-solfato sostanzialmente puri eloro impiego farmaceutico
SE8004261L (sv) Kemiska foreningar, deras framstellning samt anvendning som lekemedel
SE8500996D0 (sv) Method of treatment
ES2068714T3 (es) Derivados de pirimidina para aumentar la actividad antitumoral.
IT8621294A0 (it) Procedimento di preparazione di monosialoganglioside.
FI863565A (fi) Foerfarande foer framstaellning av nya pyrrobenzimidazoler, pyrrolbenzoxazoler och pyrrolbenztiazoler.
ZA855224B (en) Pyrrol-1-ylphenyldihydropyridazinones,their preparation and their use
DK178188D0 (da) Antivirusmiddel
ES8704962A1 (es) Un procedimiento para preparar 1b-d-ribofuranosil, 1-2-4-triazol-3-carboxamida.
KR890700352A (ko) 히드라진 설페이트를 사용하여 암환자의 생존을 연장시키는 방법
IT8721560A0 (it) Procedimento per la purificazione di interferone.
NO873727L (no) Fremgangsmaate for fremstilling av benzoksazoninforbindelser med terapeutisk aktivitet.
IT8722911A0 (it) Procedimento per la preparazione di monosialoganglioside.
FR2123632A6 (en) Prepn of 5-azacytosines and 5-azacytidines - from bis trimethylsilyl-5-azacytosine
ES2019583B3 (es) Composicion para el tratamiento de infecciones.
DK452788A (da) Smertestillende praeparat
IT8383490A0 (it) Barella per sollevamento di traumatizzati senza necessita' del loro preventivo spostamento.
ES2059306T3 (es) Utilizacion del 2,2-difenoxi-n,n-dimetilaminoetano para la mejora de la oxigenacion cerebral.
MX9203508A (es) 1,7-difenil-3-metilaza -7-ciano-8-metilnonano para usarse en el tratamiento de enfermedades.

Legal Events

Date Code Title Description
A201 Request for examination
AMND Amendment
E902 Notification of reason for refusal
AMND Amendment
E601 Decision to refuse application
J2X1 Appeal (before the patent court)

Free format text: APPEAL AGAINST DECISION TO DECLINE REFUSAL

G160 Decision to publish patent application
B701 Decision to grant
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20110314

Year of fee payment: 15

EXPY Expiration of term